Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011)

Vanda Pharmaceuticals' (VNDA) quarterly Current Deferred Tax Assets came in at $182000.0 in Q3 2011, little changed quarter-over-quarter from $182000.0 in Q2 2011.

Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Vanda Pharmaceuticals has disclosed Current Deferred Tax Assets across 2 years of filings, most recently posting $182000.0 for Q3 2011.

  • Current Deferred Tax Assets for Q3 2011 came in at $182000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2011 was $182000.0 (changed N/A YoY), and the FY2010 annual result was $182000.0, changed N/A from the prior year.
  • Current Deferred Tax Assets came in at $182000.0 for Q3 2011 at Vanda Pharmaceuticals, roughly flat from $182000.0 in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $182000.0 in Q4 2010 to a low of $182000.0 in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Vanda Pharmaceuticals 345.46 Mn 143.15 Mn 48.56 Mn

Historic Data

Download Data
DateValue
Sep 30, 2011 182,000.00
Sep 30, 2011 182,000.00
Jun 30, 2011 182,000.00
Jun 30, 2011 182,000.00
Dec 31, 2010 182,000.00
Dec 31, 2010 182,000.00